Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.

Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.